<DOC>
	<DOCNO>NCT01075854</DOCNO>
	<brief_summary>This prospective , observational study woman use Gonal-F filled-by-mass ( FbM ) ovarian hyperstimulation part in-vitro fertilization ( IVF ) intracytoplasmic sperm injection ( ICSI ) treatment infertility clinic Korea . The purpose study ass Gonal-F FbM practical set encompass subject group local practice .</brief_summary>
	<brief_title>An Observational Study Gonal-F Filled Mass Pens Multifollicular Stimulation Prior In-vitro Fertilization ( IVF ) Intracytoplasmic Sperm Injection ( ICSI )</brief_title>
	<detailed_description>Follicle stimulate hormone ( FSH ) complex hetero-dimeric glycoprotein use therapeutically stimulate follicular development ovary . The technical advance recombinant technology manufacture FSH result biochemically pure FSH preparation high batch-to-batch consistency . The protein content reliably quantify mass unit size exclusion high performance liquid chromatography . These development enable recombinant human FSH follitropin alfa ( Gonal-F ) fill release vial basis mass variability Â±2 % . In one study , FbM batch appear deliver consistent therapeutic effect filled-by-bioassay batch . In another randomized trial , self-administration subject ' satisfaction significantly high pen device group conventional syringe group . Local reaction injection sit pain significantly high conventional syringe group pen device group . The author conclude pen device Gonal-F safe , convenient , less painful , subject satisfaction conventional syringe form . This prospective , multicentric , observational study plan woman use Gonal-F FbM ovarian hyperstimulation part IVF/ICSI treatment infertility clinic Korea . Subjects fulfil eligibility criterion shall enrol consecutive manner 9-month period ( approximately 1500 subject ) . OBJECTIVES Primary objective : - To assess effectiveness Gonal-F FbM Secondary objective : - To assess safety subject convenience Gonal-F FbM normal clinical practice period 9 month</detailed_description>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<criteria>Women prescribe GonalF FbM treat physician IVF/ICSI treatment cycle eligible study Subjects hypersensitivity follitropin alfa , FSH excipients Subjects tumor hypothalamus pituitary gland Ovarian enlargement cyst due polycystic ovarian disease Gynecological hemorrhage unknown etiology Ovarian , uterine mammary carcinoma Primary ovarian failure Malformations sexual organ incompatible pregnancy Fibroid tumor uterus incompatible pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Gonal-F</keyword>
	<keyword>Multifollicular stimulation</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>Ovarian hyperstimulation</keyword>
	<keyword>In vitro fertilization</keyword>
	<keyword>Intracytoplasmic sperm injection</keyword>
	<keyword>Infertility</keyword>
</DOC>